Catalysing Translational Research and Diagnostic Development for Precision Health

Delve into the tranformative journey from the National Precision Medicine (NPM) datasets to the development of a customised genetic test to screen for common severe recessive diseases among Singaporeans. Witness first-hand how its implementation can potentially make a tangible difference to patient care and outcomes.

The event will also mark a strategic partnership between Precision Health Research, Singapore (PRECISE) and Diagnostics Development Hub (DxD Hub), a national platform hosted by A*STAR. This partnership is dedicated to productising diagnostics based on data insights and discoveries from the Singapore National Precision Medicine (NPM) programme.

This session also serves as an industry networking and engagement opportunity, bringing together Innovation and Enterprise (I&E) units and industry partners within the diagnostics and medtech sectors.

Missed the event? Catch up on the highlights here.